Sodium Valproate Syrup

Description

Sodium Valproate Oral Syrup (200 mg / 5 ml)

Healthy Inc is a specialized global supplier and exporter of advanced neurology, pediatric, and mental health therapeutics. We provide ultra-high-purity, kinetically stable Sodium Valproate Syrup, manufactured in WHO–GMP certified, high-precision liquid manufacturing facilities. This “Broad-Spectrum Anticonvulsant” is a critical strategic export to neurology clinics, pediatric hospitals, and international B2B distributors, serving as the globally preferred intervention for the management of various types of epilepsy and bipolar disorder in children.

Product Overview

This formulation operates as a “Multi-Channel Neuronal Stabilizer.” It physically alters the chemical balance of the brain to suppress abnormal electrical activity without causing excessive sedation.

• Mechanism 1 (GABA Enhancement): It physically inhibits the enzymes that break down GABA (Gamma-Aminobutyric Acid). This increases the concentration of this inhibitory neurotransmitter, chemically “quieting” overactive neurons.

• Mechanism 2 (Sodium Channel Blockade): It physically limits the firing of high-frequency neurons by acting on Voltage-Gated Sodium Channels, preventing the spread of a seizure.

• Mechanism 3 (Calcium Channel Modulation): It physically reduces T-type calcium currents, which is the specific mechanism required to treat Absence Seizures (Petit Mal).

Product Composition & Strength

We supply this product as a Sterile, Clear, Red or Colorless Liquid, optimized for high bioavailability and precision pediatric dosing.

Technical & Logistics Specifications

• HS Code: 3004.90.99 (Medicaments acting on the nervous system / Others)

• CAS Number: 1069-66-5 (Sodium Valproate)

• Dosage Form: Oral Liquid (Syrup)

• Packaging: 100 ml / 200 ml / 300 ml Amber PET or Glass Bottles with child-resistant caps. Our specialized packaging ensures 36-month stability in Zone IVb tropical climates.

Manufacturing Authority & Compliance

• Precision Potency Maintenance: Sodium Valproate is highly hygroscopic. Our manufacturing process utilizes Advanced Atmospheric Control to ensure the syrup remains chemically stable and does not degrade into valproic acid before ingestion.

• Aseptic Liquid Filling: We utilize Automated Liquid Filling Lines with 100% microbial testing to ensure total safety for chronic pediatric use.

• Sugar-Free Options: We offer specialized Sugar-Free formulations, making the product physically safe for long-term use without risking dental caries in children.

Primary Indications

• Pediatrics: Management of Generalized, Focal, and Absence Seizures.

• Neurology: Treatment of Myoclonic Epilepsy and Lennox-Gastaut Syndrome.

• Psychiatry: Management of manic episodes associated with Bipolar Disorder.

• Prophylaxis: Prevention of Migraine Headaches (in older children and adults).

Dosage & Administration

• Initial Dose: Typically 10 mg/kg to 15 mg/kg daily, physically increased in weekly intervals until seizure control is achieved.

• Maintenance: Usually 20 mg/kg to 30 mg/kg per day in divided doses.

• Administration: It is physically best to take the syrup with or after food to minimize gastrointestinal irritation.

• Consistency: It is physically critical to take the medicine at the exact same time every day to maintain stable plasma levels.

Safety Warning: For Oral Use Only. Liver Note: Physicians must physically monitor Liver Function (LFTs) regularly, especially during the first 6 months. Pancreas Note: Immediately consult a doctor if the child experiences severe abdominal pain (risk of pancreatitis). STRICT CONTRAINDICATION: Teratogenic Risk: Must not be used in female children of childbearing potential unless a pregnancy prevention program is in place. Do not use in patients with mitochondrial disorders or severe hepatic dysfunction.

Global Export & Contract Manufacturing

Healthy Inc is a premier Neurology and Pediatric Pharmaceutical Exporter in India. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) for high-volume Sodium Valproate syrups. Whether you are a National Epilepsy Program in the CIS or a B2B Pharma Marketplace partner in Africa or SE Asia, we ensure secure, WHO-GMP compliant delivery.